Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 21, 2014

View Archived Issues

OncoSec Medical and Plexxikon explore combination immunotherapy

AZD-1446 formulations tested for L-DOPA-induced dyskinesia

OMS-721 inhibits thrombus formation in ex vivo pathophysiologic system of aHUS

Preclinical data on effect of Nuvilex's pancreatic cancer treatment on ascites fluid formation

Canadian group discloses novel prodrugs of AR modulators

Duchenne muscular dystrophy is first target of Rosetta Genomics and Marina Biotech alliance

Cynapsus Therapeutics reports topline results from phase II trial of APL-130277

Diaxonhit initiates clinical study of Dx15 molecular test for thyroid cancer

First-in-human phase I promising results of afuresertib in recurrent ovarian cancer

ARMOR2 results: activity of galeterone in CRPC with AR-V7 variant

First demonstration of clinical activity of AG-120 a first-in-class inhibitor of mutated IDH1

New financings support Northwest Biotherapeutics' development of DCVax-L and DCVax-Direct

Veltuzumab receives FDA orphan drug status for pemphigus

AstraZeneca Canada confirms global lung cancer study of MED-14736

R-Pharm enters into an agreement with Bristol-Myers Squibb for Reyataz

BeneVir closes Series A investment

ALK seeks European approval for house dust mite sublingual allergy immunotherapy

Actelion Pharmaceuticals reports discovery of antibacterial compounds

Piramal Enterprises synthesizes novel TNF-alpha and IL-17 release inhibitors

Arena Pharmaceuticals reports development of Mas receptor modulators

Activity of novel PEGylated anti-IL-17A aptamer tested in models of rheumatoid arthritis

Gilead buys neglected disease priority review voucher from Knight Therapeutics

Evacetrapib improves cholesterol efflux in patients with dyslipidemia

Merz Pharma patents new 5-HT1A and 5-HT1B agonists

FDA approves opioid analgesic Hysingla ER

RSV F vaccine receives fast track to protect infants via maternal immunization

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...